Carrier-mediated uptake of clonidine in cultured human lung cells

被引:0
|
作者
Marc Le Vée
Elodie Jouan
Olivier Fardel
机构
[1] Institut de Recherches en Santé,
[2] Environnement et Travail (IRSET),undefined
[3] UMR INSERM U1085,undefined
[4] Université de Rennes 1,undefined
[5] Pôle Biologie,undefined
[6] Centre Hospitalier Universitaire,undefined
来源
Naunyn-Schmiedeberg's Archives of Pharmacology | 2018年 / 391卷
关键词
Clonidine; Uptake; Carrier; Transport; Lung; Pneumophilic drugs;
D O I
暂无
中图分类号
学科分类号
摘要
The lung is a preferential organ site for accumulation of lipophilic basic amine drugs, so-called pneumophilic drugs and belonging to various pharmacological classes, which can result in lung toxicity. In order to investigate the mechanism involved in such pulmonary accumulation of drugs, uptake of clonidine, used here as a prototypical basic amine drug, was characterized in cultured human lung cells. Clonidine accumulation in lung alveolar A549 cells was found to be temperature- and pH-dependent; it was saturable, with a Michaelis–Menten affinity constant (Km) value of 569.4 μM. Various pneumophilic drugs, including amitriptyline, verapamil, propranolol, chlorpromazine, imipramine, and quinidine, markedly cis-inhibited clonidine uptake in A549 cells, in a dose-dependent manner for at least some of them. They additionally trans-stimulated clonidine efflux from A549 cells, thus suggesting that they are substrates for the putative clonidine transporter. In addition to alveolar A549 cells, bronchial epithelial BEAS-2B cells as well as lung endothelial HULEC-5a cells were found to exhibit clonidine accumulation abrogated by amitriptyline, verapamil, and chlorpromazine. Taken together, these data likely provided evidence for carrier-mediated uptake of clonidine in human lung cells. This carrier, which remains to be molecularly identified, interacts with various pneumophilic drugs, suggesting that it may contribute to lung accumulation of these drugs in a notable way.
引用
收藏
页码:361 / 369
页数:8
相关论文
共 50 条
  • [21] Carrier-mediated uptake of YM155, a novel survivin suppressant, into human cancer cells in vitro
    Minematsu, Tsuyoshi
    Iwai, Megumi
    Nakahara, Takahito
    Usui, Takashi
    Kamimura, Hidetaka
    DRUG METABOLISM REVIEWS, 2006, 38 : 112 - 112
  • [22] Uptake of 5-methyltetrahydrofolate into PC-3 human prostate cancer cells is carrier-mediated
    Horne, DW
    Reed, KA
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2003, 14 (08): : 473 - 479
  • [23] Inhibitors of the carrier-mediated influx of auxin in suspension-cultured tobacco cells
    Viviane Imhoff
    Philippe Muller
    Jean Guern
    Alain Delbarre
    Planta, 2000, 210 : 580 - 588
  • [24] Carrier-Mediated and Energy-Dependent Uptake and Efflux of Deoxynivalenol in Mammalian Cells
    Li, Xiaoming
    Mu, Peiqiang
    Wen, Jikai
    Deng, Yiqun
    SCIENTIFIC REPORTS, 2017, 7
  • [25] CARRIER-MEDIATED CHOLINE UPTAKE BY KREBS-II ASCITES-CELLS
    RIBBES, G
    HAMZA, M
    CHAP, H
    DOUSTEBLAZY, L
    BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 818 (02) : 183 - 190
  • [26] Carrier-Mediated and Energy-Dependent Uptake and Efflux of Deoxynivalenol in Mammalian Cells
    Xiaoming Li
    Peiqiang Mu
    Jikai Wen
    Yiqun Deng
    Scientific Reports, 7
  • [27] CARRIER-MEDIATED SULFATE TRANSPORT IN HUMAN URETERAL EPITHELIAL-CELLS CULTURED IN SERUM-FREE MEDIUM
    ELGAVISH, A
    WILLE, JJ
    RAHEMTULLA, F
    DEBRO, L
    AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (05): : C916 - C926
  • [28] Carrier-mediated hepatic uptake of quinolone antibiotics in the rat
    Sasabe, H
    Terasaki, T
    Tsuji, A
    Sugiyama, Y
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 282 (01): : 162 - 171
  • [29] CARRIER-MEDIATED ACETATE UPTAKE IN CORYNEBACTERIUM-GLUTAMICUM
    EBBIGHAUSEN, H
    WEIL, B
    KRAMER, R
    ARCHIVES OF MICROBIOLOGY, 1991, 155 (05) : 505 - 510
  • [30] AUXIN TRANSPORT IN SUSPENSION-CULTURED SOYBEAN ROOT-CELLS .2. ANION EFFECTS ON CARRIER-MEDIATED UPTAKE
    LOPER, MT
    SPANSWICK, RM
    PLANT PHYSIOLOGY, 1991, 96 (01) : 192 - 197